Prospective Cohort Study of Rapid Response Team

Hospital Rapid Response Team Clinical Trial

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02986581
• Other study ID #: SAFER_20161101
• Status: Recruiting
• Start date: November 2016
• Est. completion date: November 2026

Study information

• Verified date: June 2021
• Source: Seoul National University Hospital
• Contact: Yeon Joo Lee, MD
• Email: yjlee1117[@]snubh.org
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The purpose of this study is to collect data of rapid response team activated patients prospectively

Description:

acutely deteriorating patients including sudden cardiac arrest in general ward who are monitored and intervened by rapid response team

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 79800
• Est. completion date: November 2026
• Est. primary completion date: November 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 15 Years and older

Eligibility

Inclusion Criteria:

• Patients admitted to general ward in Seoul National University Bundang Hospital and monitored by in-hospital rapid response system.

Exclusion Criteria:

• patients admitted to pediatric wards

• patients in emergency room, intensive care unit, and operating room

Related Conditions & MeSH terms

• Emergencies
• Hospital Medical Emergency Team
• Hospital Rapid Response Team
• Medicine, Emergency

Locations

Country	Name	City	State
Korea, Republic of	Seoul National University Bundang Hospital	Seongnam-si

Sponsors (2)

Lead Sponsor	Collaborator
Seoul National University Hospital	Seoul National University Bundang Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	mortality or ICU admission of rapid response team activated patient		an average of 1 year
Primary	incidence of preventable cardiac arrest		an average of 1 year
Secondary	Frequency of triggerring criteria(1) for activation of rapid response team	SBP <90mmHg(mABP 60mmHg) +- clinically correlated symptom or sign	an average of 1 year
Secondary	Frequency of triggerring criteria(2) for activation of rapid response team	HR: <50/min or >140/min or symptomatic arrythmia	an average of 1 year
Secondary	Frequency of triggerring criteria(3) for activation of rapid response team	RR: <10/min or >30/min or stridor(sign of airway obstruction) or accessary muscle use	an average of 1 year
Secondary	Frequency of triggerring criteria(4) for activation of rapid response team	Oxygenation: SaO2 <90% in room air or FM 8L/min	an average of 1 year
Secondary	Frequency of triggerring criteria(5) for activation of rapid response team	Metabolic acidosis: Lactic acid<2.5 , TCO2 <15	an average of 1 year
Secondary	Frequency of triggerring criteria(6) for activation of rapid response team	ABGA abnormality : PaCO2>50 or pH<7.3 or PaO2<60	an average of 1 year
Secondary	Frequency of triggerring criteria(7) for activation of rapid response team	ABGA abnormality : PaCO2>50 or pH<7.3 or PaO2<60	an average of 1 year
Secondary	Frequency of triggerring criteria(8) for activation of rapid response team	Any serious concern about overall deterioration detected by doctor, nurse and caregiver at bedside	an average of 1 year